Osteoporosis, Post-menopausal: Clinical Trials

4 completed. 4 Phase 4.

By phase and status

Phase	Trials	Status
Phase 4	4	Completed 4

Follow Osteoporosis, Post-menopausal: new trials by email Literature Review of Osteoporosis, Post-menopausal trials Research Report on Osteoporosis, Post-menopausal

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

Trial	Phase	Status	Sponsor	Enrollment	Start	Updated
Effects of Teriparatide or Zoledronic Acid Treatment on Bone in Postmenopausal Osteoporotic Women Teriparatide, Zoledronic Acid - Osteoporosis, Post-menopausal	Phase 4	Completed	Eli Lilly and Company	69	2009-07-01	2013-04-04
Bone Marker Changes With Teriparatide/Postmenopausal Osteoporosis Teriparatide - Osteoporosis, Post-Menopausal	Phase 4	Completed	Eli Lilly and Company	45	2003-04-01	2007-09-20
Long Term Effects of Raloxifene Treatment on Bone Quality Raloxifene, Placebo - Osteoporosis, Post-Menopausal	Phase 4	Completed	Eli Lilly and Company	31	2003-04-01	2007-09-20
Carotid Artery Intima-Media Thickness Following Exposure to Raloxifene or Placebo raloxifene, Placebo - Osteoporosis, Post-Menopausal	Phase 4	Completed	Eli Lilly and Company	147	2003-03-01	2007-09-20

Narrower conditions

Osteoporosis, Postmenopausal (4)  ·  Osteoporosis (1)

Broader conditions

Bone Diseases (4)  ·  Bone Diseases, Metabolic (4)  ·  Metabolic Diseases (4)  ·  Musculoskeletal Diseases (4)  ·  Nutritional and Metabolic Diseases (4)  ·  Osteoporosis (3)

Interventions

Raloxifene Hydrochloride (2)  ·  Teriparatide (2)  ·  Zoledronic Acid (1)

Sponsors

Eli Lilly and Company (4)

Countries

United States (3)  ·  Canada (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Puerto Rico (1)  ·  Spain (1)

Results publications

PMID 26841258